AbSci
  • Our Technology
  • Partnerships
  • About Us
  • Careers
  • News / Updates
  • Contact
  • Facebook
  • Twitter
  • Linkedin
Select Page

Daniel Gold, Ph.D. Appointed to AbSci’s Board of Directors

May 16, 2016 | Announcement, Press

PORTLAND, Ore., May 16, 2016 /PRNewswire/ — AbSci announced today the appointment of Daniel Gold, Ph.D. to AbSci’s Board of Directors. Dr. Gold has served in senior management roles at several leading biotechnology companies and currently serves as Vice...

AbSci Appoints V. Bryan Lawlis, Ph.D. to AbSci’s Board of Directors

May 2, 2016 | Announcement, News, Press

PORTLAND, Ore., May 2, 2016 /PRNewswire/ — AbSci announced today the appointment of V. Bryan Lawlis, Ph.D. to AbSci’s Board of Directors. Dr. Lawlis has been the CEO and founder of numerous biotechnology companies and currently serves on the Board of...

Recent Posts

  • AbSci Announces Acquisition of Deep Learning Company Denovium
  • AbSci to Present at the 39th Annual J.P. Morgan Healthcare Conference
  • AbSci Announces Recent Additions to Board of Directors
  • AbSci Announces $65 Million Financing Led by Casdin Capital
  • Alpha Cancer Technologies to License AbSci’s SoluPro Strain for the Expression of Alpha-Fetoprotein

Archives

  • January 2021
  • November 2020
  • October 2020
  • September 2020
  • January 2020
  • July 2019
  • March 2019
  • January 2019
  • December 2018
  • November 2018
  • October 2018
  • September 2018
  • July 2018
  • May 2018
  • February 2018
  • January 2018
  • December 2017
  • October 2017
  • August 2017
  • April 2017
  • January 2017
  • October 2016
  • August 2016
  • May 2016
  • April 2016
  • October 2015
SEE ARCHIVE

Categories

  • Announcement
  • Article
  • Award
  • Fundraising
  • News
  • Press
  • Uncategorized

Designed by Elegant Themes | Powered by WordPress